Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline
remove_circle_outline

Journals

remove_circle_outline

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = radiolanthanides

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
17 pages, 4706 KiB  
Article
CERN-MEDICIS (Medical Isotopes Collected from ISOLDE): A New Facility
by Ricardo Manuel Dos Santos Augusto, Leo Buehler, Zoe Lawson, Stefano Marzari, Monika Stachura, Thierry Stora and CERN-MEDICIS collaboration
Appl. Sci. 2014, 4(2), 265-281; https://doi.org/10.3390/app4020265 - 16 May 2014
Cited by 81 | Viewed by 14955
Abstract
About 50% of the 1.4 GeV CERN (European Organization for Nuclear Research, www.cern.ch) protons are sent onto targets to produce radioactive beams by online mass separation at the Isotope Separator Online Device (ISOLDE) facility, for a wide range of studies in fundamental and [...] Read more.
About 50% of the 1.4 GeV CERN (European Organization for Nuclear Research, www.cern.ch) protons are sent onto targets to produce radioactive beams by online mass separation at the Isotope Separator Online Device (ISOLDE) facility, for a wide range of studies in fundamental and applied physics. CERN-MEDICIS is a spin-off dedicated to R&D in life sciences and medical applications. It is located in an extension of the Class A building presently under construction. It will comprise laboratories to receive the irradiated targets from a new station located at the dump position behind the ISOLDE production targets. An increasing range of innovative isotopes will thus progressively become accessible from the start-up of the facility in 2015 onward; for fundamental studies in cancer research, for new imaging and therapy protocols in cell and animal models and for pre-clinical trials, possibly extended to specific early phase clinical studies up to Phase I trials. Five hundred megabecquerel isotope batches purified by electromagnetic mass separation combined with chemical methods will be collected on a weekly basis. A possible future upgrade with gigabecquerel pharmaceutical-grade i.e., current good manufacturing practices (cGMP) batch production capabilities is finally presented. Full article
(This article belongs to the Special Issue Radioisotope Production and Applications)
Show Figures

Figure 1

Back to TopTop